
TRANSCAT INC
TRNSNASDAQTrading Snapshot
- Day Range
- $94.25 β $96.78
- 52-Week Range
- $50.23 β $96.60
- Volume
- $1.92B
- Avg Volume
- $1.84B
- Shares Outstanding
- 9.4M
- Next Earnings
- Sep 26, 2026
Fundamentals Snapshot
- Annual Revenue
- $332M
- Last Q Revenue
- $93M
- P/E Ratio
- 247.2
- P/S Ratio
- 2.4x
- EPS (TTM)
- $0.36
- Dividend Yield
- β
Why Investors Own TRNS
- βHigh-growth profile β revenue up +50.4% YoY with expanding US Equity exposure.
- βHealthy economics β 75% gross margin and 21% free-cash-flow margin.
- βNew products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
About TRANSCAT INC
Transcat, Inc. offers comprehensive calibration and instrument services for laboratories, serving clients across the United States, Canada, and other international markets. The company operates through two distinct divisions: Service and Distribution. The Service division delivers a wide array of offerings, including precision calibration, equipment repair, thorough inspections, analytical qualification, preventive maintenance, and expert consulting. This segment also features its proprietary software, CalTrak, designed to manage documents and assets while streamlining the operational workflow for its calibration centers and customer equipment. Additionally, its "Compliance, Control and Cost" online portal grants customers web-based asset management capabilities and a secure, off-site repository for calibration and other service records. The Distribution division focuses on the sale and rental of instruments for testing, measurement, and control purposes. It also provides valuable supplementary services such as the calibration and certification of newly purchased equipment, equipment leasing, sales of pre-owned machinery, and customized equipment kitting. This division engages customers through its online platform, various digital and print marketing campaigns, proactive outbound sales efforts, and an incoming call center. Transcat primarily caters to highly regulated sectors, particularly the life sciencesβencompassing pharmaceutical, biotechnology, medical device, and other FDA-regulated entities. Furthermore, it extends its services and products to aerospace and defense, industrial manufacturing, energy, utilities, and other industries where process accuracy and confirmed equipment performance are paramount. Established in 1964, Transcat, Inc. maintains its corporate headquarters in Rochester, New York.
Otter Score Breakdown
βAnalyst Ratings
βLatest News & Updates

Transcat, Inc. 2027 Q1 - Results - Earnings Call Presentation
2026-08-05. The following slide deck was published by Transcat, Inc.

Transcat, Inc. (TRNS) Q1 2027 Earnings Call Transcript
Transcat, Inc. (TRNS) Q1 2027 Earnings Call August 4, 2026 4:30 PM EDTCompany ParticipantsJohn Howe - Senior Director of Financial Planning &...
Transcat Q1 Adj. EPS $0.51 Beats $0.38 Estimate, Sales $92.945M Beat $86.546M Estimate
Transcat (NASDAQ:TRNS) reported quarterly earnings of $0.51 per share which beat the analyst consensus estimate of $0.38 by 34.21 percent. This is a 13.56 percent decrease over earnings of $0.59 per share from the same

1 Small-Cap Stock Worth Your Attention and 2 That Underwhelm
Investors looking for hidden gems should keep an eye on small-cap stocks because theyβre frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a high-risk, high-reward environment due to the lack of reliable analyst price targets.